Form 4: VolitionRx GC Nicholas Plummer Reports Acquisition of 12,043 Shares in Lieu of Cash Compensation

Nicholas Plummer, General Counsel of VolitionRx, reports acquiring 12,043 shares of common stock on September 1, 2024, as compensation in lieu of cash.

Summary

• On September 4, 2024, Nicholas Plummer, General Counsel of VolitionRx, filed a Form 4 with the SEC.
• The report details a transaction on September 1, 2024, where Plummer acquired 12,043 shares of VolitionRx common stock.
• These shares were awarded as restricted stock units (RSUs) in lieu of cash compensation under the company's 2015 Stock Incentive Plan.
• The RSUs vest in installments on September 1, 2024 (4,015 units), October 1, 2024 (4,014 units), and November 1, 2024 (4,014 units), with final vesting on June 1, 2025, subject to continued service.
• Following the transaction, Plummer beneficially owns 163,261 shares of VolitionRx common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock ownership change due to compensation. The acceptance of stock in lieu of cash could be seen as a slightly positive sign of confidence, but it's not a major indicator.

Positives

• The acceptance of RSUs in lieu of cash compensation may indicate confidence in the company's future performance by the reporting person.
• The vesting schedule incentivizes continued service by the reporting person.

Future Outlook

The vesting schedule of the RSUs suggests an expectation of continued service and contribution from the reporting person to the company's future success.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the alignment of management's interests with those of shareholders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the alignment of management's interests with shareholders through stock ownership.

Key Dates